Biggest shake-up in type 2 diabetes care in a decade unveiled

Biggest shake-up in type 2 diabetes care in a decade unveiled

By Liz Wells 20 August 2025

Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments, in the biggest shake-up in care for a decade, as part of NICE’s commitment to re-evaluate priority cli...

NICE conditionally recommends six digital platforms to support at home cardiac rehab

By Liz Wells 19 August 2025

People with heart disease will be able to do their recovery sessions from home rather than travelling for rehabilitation appointments after NICE’s independent committee conditionally recommended si...

Patients need support to keep weight off after treatment ends

By Liz Wells 05 August 2025

Patients coming off obesity medication or finishing a weight management programme should be offered support to help keep the weight off and stay healthy long-term, according to NICE’s updated quali...

NICE chief executive to step down

By Liz Wells 30 July 2025

NICE chief executive Dr Sam Roberts is to step down after four years of leadership to support her children.

NICE updates guideline for early-stage chronic heart failure

By Liz Wells 10 June 2025

NICE has updated its draft guidance on the medical treatment of early-stage chronic heart failure, which could help prevent 3,000 deaths and 5,500 hospital admissions in England.

NICE updates guidance to help cut falls and related hospital admissions

By Liz Wells 02 May 2025

Personalised assessments that consider factors, including the hazards in a person’s home and their previous medical history, will help reduce falls in older and at-risk people, according to updated...

NICE approves use of endometriosis pill

By Liz Wells 01 May 2025

A new daily pill for endometriosis has been approved for use on the NHS, which could help over a thousand women in England every year manage the symptoms of the condition.

Robotic surgery systems approved for NHS use

By Liz Wells 17 April 2025

NICE has approved 11 robotic surgery systems for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.

Targeted breast cancer treatment approved for routine NHS use

By Liz Wells 11 April 2025

NICE is recommending capivasertib with fulvestrant to treat women with advanced breast cancer, which means the drug will be funded immediately through the Cancer Drugs Fund.

NICE aims to transform rehabilitation for millions with long-term neurological conditions

By Liz Wells 09 April 2025

NICE has published draft guideline that aims to address 'inconsistent access to vital rehabilitation services' faced by millions of people living with long-term neurological conditions across England.

First daily pill for endometriosis approved for NHS use

By Liz Wells 13 March 2025

NICE has recommended the first long-term daily pill to treat endometriosis that could transform how the painful condition is managed.

frederica-diamanta

Senior Health and Safety Risk Adviser

£42,839 - £47,181 per annum

Harrogate, North Yorkshire£42,839 - £47,181 per annum

RECRUITER: North Yorkshire Council

Senior Health and Safety Risk Adviser

£42,839- £47,181 per annum

Selby, North Yorkshire£42,839- £47,181 per annum

RECRUITER: North Yorkshire Council

Senior Health and Safety Risk Adviser

£42,839- £47,181 per annum

Northallerton, North Yorkshire£42,839- £47,181 per annum

RECRUITER: North Yorkshire Council

frederica-diamanta

Senior Health and Safety Risk Adviser

£42,839 - £47,181 per annum

Harrogate, North Yorkshire£42,839 - £47,181 per annum

RECRUITER: North Yorkshire Council

Senior Health and Safety Risk Adviser

£42,839- £47,181 per annum

Selby, North Yorkshire£42,839- £47,181 per annum

RECRUITER: North Yorkshire Council

Senior Health and Safety Risk Adviser

£42,839- £47,181 per annum

Northallerton, North Yorkshire£42,839- £47,181 per annum

RECRUITER: North Yorkshire Council